Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Complications of Medical Thoracoscopy.
Nour Moursi Ahmed S, Saka H, Mohammadien HA, Alkady O, Oki M, Tanikawa Y, Tsuboi R, Aoyama M, Sugiyama K. Nour Moursi Ahmed S, et al. Among authors: tanikawa y. Adv Med. 2016;2016:3794791. doi: 10.1155/2016/3794791. Epub 2016 Jun 19. Adv Med. 2016. PMID: 27413774 Free PMC article.
Cefepime monotherapy for febrile neutropenia in patients with lung cancer.
Saito H, Takahashi K, Okuno M, Saka H, Imaizumi K, Hasegawa Y, Tanikawa Y, Yamamoto M, Taniguchi H, Shindoh J, Suzuki R, Shimokata K; Central Japan Lung Study Group. Saito H, et al. Among authors: tanikawa y. J Infect Chemother. 2014 Jun;20(6):365-9. doi: 10.1016/j.jiac.2014.02.002. Epub 2014 Mar 26. J Infect Chemother. 2014. PMID: 24679653 Clinical Trial.
A phase II study of carboplatin and paclitacel with meloxicam.
Suzuki R, Yamamoto M, Saka H, Taniguchi H, Shindoh J, Tanikawa Y, Nomura F, Gonda H, Imaizumi K, Hasegawa Y, Shimokata K. Suzuki R, et al. Among authors: tanikawa y. Lung Cancer. 2009 Jan;63(1):72-6. doi: 10.1016/j.lungcan.2008.04.002. Epub 2008 May 21. Lung Cancer. 2009. PMID: 18499296 Clinical Trial.
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y. Shindo Y, et al. Among authors: tanikawa y. Am J Respir Crit Care Med. 2013 Oct 15;188(8):985-95. doi: 10.1164/rccm.201301-0079OC. Am J Respir Crit Care Med. 2013. PMID: 23855620
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study.
Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y; Central Japan Lung Study Group. Shindo Y, et al. Among authors: tanikawa y. Lancet Infect Dis. 2015 Sep;15(9):1055-1065. doi: 10.1016/S1473-3099(15)00151-6. Epub 2015 Jul 2. Lancet Infect Dis. 2015. PMID: 26145194
Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study.
Ichikawa M, Suzuki R, Kataoka K, Noda Y, Shindoh J, Matsumoto S, Tanikawa Y, Suzuki K, Baba K, Shindo Y, Kondo M, Imaizumi K, Kume H, Hasegawa Y, Takagi K, Taniguchi H. Ichikawa M, et al. Among authors: tanikawa y. Lung Cancer. 2010 Sep;69(3):319-22. doi: 10.1016/j.lungcan.2009.11.021. Epub 2010 Jan 6. Lung Cancer. 2010. PMID: 20053476 Clinical Trial.
75 results